Pharmacokinetic Issues of Moxifloxacin Plus Rifapentine

NCT00460759 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Mycobacterium Tuberculosis

Interventions

DRUG: Moxifloxacin
DRUG: Rifapentine

Sponsor

Johns Hopkins University